Semi-Annual Consolidated Statement Of Cash Flows

EnBio Holdings,Inc - Filing #7325108

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
1,065,972,000 JPY
394,270,000 JPY
152,226,000 JPY
1,232,759,000 JPY
Depreciation
430,513,000 JPY
392,235,000 JPY
Impairment losses
JPY
110,569,000 JPY
Amortization of goodwill
8,008,000 JPY
8,008,000 JPY
Increase (decrease) in allowance for doubtful accounts
-3,322,000 JPY
-172,000 JPY
Interest and dividend income
-45,042,000 JPY
-36,234,000 JPY
Interest expenses
114,663,000 JPY
124,895,000 JPY
Foreign exchange losses (gains)
-187,229,000 JPY
-69,726,000 JPY
Decrease (increase) in trade receivables
-471,974,000 JPY
802,206,000 JPY
Decrease (increase) in inventories
787,309,000 JPY
155,920,000 JPY
Increase (decrease) in trade payables
537,137,000 JPY
-220,220,000 JPY
Other, net
44,224,000 JPY
45,840,000 JPY
Subtotal
2,067,467,000 JPY
2,597,032,000 JPY
Interest and dividends received
30,994,000 JPY
28,944,000 JPY
Interest paid
-115,599,000 JPY
-125,601,000 JPY
Net cash provided by (used in) operating activities
1,663,431,000 JPY
1,989,080,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,079,075,000 JPY
-1,162,712,000 JPY
Purchase of investment securities
-1,888,000 JPY
-23,685,000 JPY
Loan advances
-280,085,000 JPY
-552,456,000 JPY
Other, net
-27,858,000 JPY
-17,246,000 JPY
Net cash provided by (used in) investing activities
-1,583,696,000 JPY
-1,770,420,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,987,400,000 JPY
1,349,902,000 JPY
Redemption of bonds
-36,500,000 JPY
-35,000,000 JPY
Repayments of long-term borrowings
-2,498,317,000 JPY
-1,208,477,000 JPY
Proceeds from issuance of shares
1,056,000,000 JPY
JPY
Dividends paid
-52,965,000 JPY
-52,892,000 JPY
Net cash provided by (used in) financing activities
638,922,000 JPY
240,727,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
-1,500,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
7,821,000 JPY
-2,368,000 JPY
Net increase (decrease) in cash and cash equivalents
726,478,000 JPY
457,019,000 JPY
Cash and cash equivalents
3,574,064,000 JPY
2,798,635,000 JPY
2,341,616,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.